Stephane Droupy

Nimes, 30029, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 122 publications

Quantitative CT biomarkers for predicting clinical outcomes after prostatic artery embolization: Results of the prospective pilot EMBOPERF study.

Quantitative CT biomarkers for predicting clinical outcomes after prostatic artery embolization: Results of the prospective pilot EMBOPERF study.

Journal: Diagnostic and interventional imaging

Published: February 19, 2026

Adjustable retropubic sling (Remeex®) for the treatment of male stress-urinary-incontinence after prostatectomy: Middle-term results and patient satisfaction.

Adjustable retropubic sling (Remeex®) for the treatment of male stress-urinary-incontinence after prostatectomy: Middle-term results and patient satisfaction.

Journal: The French journal of urology

Published: November 08, 2025

Efficacy and safety of intracavernosal incobotulinumtoxinA (Xeomin) as add-on therapy to sildenafil for the treatment of erectile dysfunction insufficiently responsive to phosphodiesterase type 5 inhibitors.

Efficacy and safety of intracavernosal incobotulinumtoxinA (Xeomin) as add-on therapy to sildenafil for the treatment of erectile dysfunction insufficiently responsive to phosphodiesterase type 5 inhibitors.

Journal: The journal of sexual medicine

Published: May 29, 2025

Predicting early clinical success of prostate artery embolization using MRI perfusion in benign prostatic hyperplasia.

Predicting early clinical success of prostate artery embolization using MRI perfusion in benign prostatic hyperplasia.

Journal: CVIR endovascular

Published: March 25, 2025

Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 Trial.

Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 14, 2025

Long-term results of artificial urinary sphincter in women: A retrospective monocentric study.

Long-term results of artificial urinary sphincter in women: A retrospective monocentric study.

Journal: The French journal of urology

Published: June 24, 2024

Kidney cancer following occupational exposure to trichloroethylene: Clinical case series and review of the literature.

Kidney cancer following occupational exposure to trichloroethylene: Clinical case series and review of the literature.

Journal: The French journal of urology

Published: April 10, 2024

Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life.

Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life.

Journal: BMJ open

Published: December 21, 2023

Robot-assisted approach versus open surgery and conventional laparoscopy for radical prostatectomy for prostate cancer: a micro-costing study.

Robot-assisted approach versus open surgery and conventional laparoscopy for radical prostatectomy for prostate cancer: a micro-costing study.

Journal: Health economics review

Published: September 29, 2023

Single-Probe Percutaneous Cryoablation with Liquid Nitrogen for the Treatment of T1a Renal Tumors.

Single-Probe Percutaneous Cryoablation with Liquid Nitrogen for the Treatment of T1a Renal Tumors.

Journal: Cancers

Published: September 17, 2023

Parietal complications after cystectomy: Incisional and parastomal hernia, epidemiology and risk factors.

Parietal complications after cystectomy: Incisional and parastomal hernia, epidemiology and risk factors.

Journal: The French journal of urology

Published: September 11, 2023

Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial.

Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial.

Journal: The Lancet regional health. Europe

Published: May 10, 2023

Showing 1-12 of 122

Last Updated: 09/26/2026